Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
11/2008
11/12/2008CN101301283A Composition transferred through nose and brain containing milnacipran
11/12/2008CN101301279A Sumatriptan succinate rapid disintegrating tablet and preparation thereof
11/12/2008CN101301275A Method for preparing nicotine containing oral dosage form
11/12/2008CN101301089A Medicinal meat balls for curing insomnia
11/12/2008CN100432077C N-sulfonylaminothiazole
11/12/2008CN100432075C Diazabicyclic aryl derivatives as nicotinic acetylcholine receptor ligands
11/12/2008CN100432070C Novel sulfamides and their use as endothelin receptor antagonists
11/12/2008CN100432062C Terphenyl derivatives, preparation thereof, compositions containing same
11/12/2008CN100432056C Tetrahydroisoquinolyl acetamide derivatives for use as orexin receptor antagonists
11/12/2008CN100432055C Tricyclic protein kinase inhibitors
11/12/2008CN100432053C Crystalline Alipiprazole and its prepn
11/12/2008CN100432049C Cycloalkene derivatives, process for producing the same and use
11/12/2008CN100431633C Drug delivery system for conscious sedation
11/12/2008CN100431599C Brain protein hydrolysate and production process of its freeze dried preparation
11/12/2008CN100431593C Chinese medicinal formulation for treating hydrocephalus
11/12/2008CN100431589C Fragrant pillow prepared from medicine for protecting and stengthening health
11/12/2008CN100431567C Use of delphinium glabra plant for preparing drug for stopping pain, hemostasis and anticancer
11/12/2008CN100431556C Preparation method of betulin extract, application and its composition
11/12/2008CN100431543C Pharmaceutical composition
11/12/2008CN100431541C Phentanyl-containing adhesive patch for application to oral-cavity mucosa
11/12/2008CN100431539C Use of acetylchloinesterase inhibitor for preparing medicine for treating parkinson's disease
11/12/2008CN100431536C Alpha 2b 0r 2b/2c adrenoceptor agonists for the treatment of neurodegeneration
11/11/2008US7449585 1,2-dihydro-2-(4-trifluoromethylphenyl)-6-(3-trifluoromethyl-2-pyridinyl)-3H-indazol-3-one; capsaicin receptor ; analgesic, antiinflammatory, hypotensive agent; rheumatoid arthritis, osteoarthritis, headache, migraine, cancer and central nervous system pain, irritable bowel syndrome
11/11/2008US7449581 6-Substituted pyrido-pyrimidines
11/11/2008US7449557 Complexes of alpha (2) macroglobulin and antigenic molecules for immunotherapy
11/11/2008US7449492 Therapeutic agents—I
11/11/2008US7449490 Pharmaceutically active compounds and methods of use
11/11/2008US7449487 In particular of avocado, soya bean and/or lupin oils, for preparation of a medicament intended to stimulate expression of TGF-62 or expression of the plasminogen activator inhibitor PAI-1
11/11/2008US7449475 e.g. 2-{[(2S)-3-(5-Chloro-1'H,3H-spiro[1-benzofuran-2,4'-piperidin]-1'-yl)-2-hydroxypropyl]oxy}-N-cyclopropylbenzamide; macrophage inflammatory protein (MIP)-1 alpha chemokine receptor modulator; antiinflammatory, antiproliferative agent, autoimmune diseases
11/11/2008US7449472 Methods of inhibiting p38 with substituted bicyclic pyrimidines
11/11/2008US7449470 Antagonists to treat neurodegenerative diseases like Parkinson's disease; 2,4,6-trisubstituted pyrimidines; N-(2,6-diphenyl-pyrimidin-4-yl)-benzamide
11/11/2008US7449466 Cyclic aminophenyl sulfamate derivative
11/11/2008US7449448 Administering fructose of fructose containing oligosaccharide
11/11/2008US7449446 Synergistic mixture; anticoagulants
11/11/2008US7449198 Stable salts of O-acetylsalicylic acid with basic amino acids
11/11/2008US7449175 Delivery of erectile dysfunction drugs through an inhalation route
11/11/2008US7449174 Delivery of analgesics through an inhalation route
11/11/2008US7449173 heating drugs used for the treatment of anxiety or insomnia, coated on solid supports to form vapors and condensing the vapor to form aerosols comprising microstructure particles of the drugs
11/11/2008US7449172 Delivery of antiemetics through an inhalation route
11/11/2008CA2588361A1 Methods of treatment and prevention of neurodegenerative diseases and disorders
11/06/2008WO2008134553A1 Methods of using bicyclic compounds in treating sodium channel-mediated diseases
11/06/2008WO2008134547A1 Methods of using hydroxycyclohexane and hydroxypiperidine compounds in treating sodium channel-mediated diseases or conditions
11/06/2008WO2008134525A1 Deuterium labelled ketamine
11/06/2008WO2008134480A1 Non-basic melanin concentrating hormone receptor-1 antagonists
11/06/2008WO2008133952A2 Transmucosal treatment with fentanyl in patients with mucositis
11/06/2008WO2008133709A2 Targeted split biomolecular conjugates for the treatment of diseases, malignancies and disorders, and methods of their production
11/06/2008WO2008133330A1 Stable solid preparation comprising 4,5-epoxymorphinan derivative
11/06/2008WO2008133297A1 Therapeutic or prophylactic agent for dyskinesia
11/06/2008WO2008133274A1 Aminodihydrothiazine derivatives substituted with cyclic groups
11/06/2008WO2008133273A1 Pharmaceutical composition for treatment of alzheimer's disease
11/06/2008WO2008133208A1 Method for enhancing immune response with peptide
11/06/2008WO2008133192A1 Fused imidazole compound and use thereof
11/06/2008WO2008133128A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133127A1 Fused heterocyclic derivative, pharmaceutical composition comprising the derivative, and use of the composition for medical purposes
11/06/2008WO2008133021A1 COMPOSITION FOR AMELIORATING OPTIC NERVE DISORDER COMPRISING PROSTAGLANDIN F2α COMPOUND AS ACTIVE INGREDIENT
11/06/2008WO2008132729A2 Promoters exhibiting endothelial cell specificity and methods of using same for regulation of angiogenesis
11/06/2008WO2008132712A2 Combination pharmaceutical compositions
11/06/2008WO2008132710A2 Pharmaceutical nimodipine compositions
11/06/2008WO2008132589A1 Combinations comprising pregabalin
11/06/2008WO2008132464A2 Mek5 and related proteins as biomarkers of neurodegenerative diseases
11/06/2008WO2008132454A1 Carbolines and their use as imaging agents
11/06/2008WO2008132162A1 3- (sulphonylamino) -phenyl-2 -hydroxy-ethylamino derivatives useful as beta-agonists, processes for preparing them and their use as medicaments
11/06/2008WO2008131947A1 Substituted sulfonamide derivatives
11/06/2008WO2008131922A1 New 4,8-diphenyl-polyazanaphthalene derivatives
11/06/2008WO2008131779A1 Isoquinolinone derivatives as nk3 antagonists
11/06/2008WO2008131567A1 Solvent-free crystalline form of naltrexone
11/06/2008WO2008116663A3 Heterocyclyl-substituted-tetrahydro-naphthalen-amine derivatives, their preparation and use as medicaments
11/06/2008WO2008100456A3 Functionally selective alpha2c adrenoreceptor agonists
11/06/2008WO2008095086A3 Topiramate plus naltrexone for the treatment of addictive disorders
11/06/2008WO2008078196A3 Substituted heteroaryl pyridopyrimidone derivatives
11/06/2008WO2008076046A8 Novel 2-amino-5, 5-diaryl-imidazol-4-ones
11/06/2008WO2008073395A3 Compositions and methods for cardiac tissue protection and regeneration
11/06/2008WO2008020306A3 Isoindole derivatives
11/06/2008WO2008009476A3 Concentrated methotrexate solutions
11/06/2008WO2007127475A3 Pyridazines for demyelinating diseases and neuropathic pain
11/06/2008US20080275131 Compositions of (-)-e-10-oh-nt and methods for their synthesis and use
11/06/2008US20080275130 Novel Derivatives of 3.5-Seco-4-Norcholestane and Use Thereof
11/06/2008US20080275129 Such as spinal chord injury by administration of guanabenz; glycosaminoglycans; ointments
11/06/2008US20080275112 3-Aminoadamantane-1-carboxylic acid derivatives in which position 5 or 7 of the adamantane skeleton has been optionally substituted; coupling of monomeric amino acid derivatives to oligomers; antiviral agents GABA analogues, oligopeptides, ion channel modulators, and peptidic catalysts
11/06/2008US20080275100 For inducing general anesthesia, sedation, and/or hypnotic or sleep effects in patient
11/06/2008US20080275088 Use of Collismycin and Derivatives Thereof as Oxidative Stress Inhibitors
11/06/2008US20080275082 Comprising NK3 receptor antagonist talnetant, povidone, erythritol and Sodium Lauryl Sulfate; erythritol used as soluble filler in preparation of stable drug; dosage tablet or capsule
11/06/2008US20080275075 Medicine Comprising a Combination of an Acetylcholinesterase Inhibitor and a 5-Substituted-3-Oxadiazolyl-1,6-Naphthyridin-2(1H)-One Derivative
11/06/2008US20080275069 3,8-dimethyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]-4(3H)-quinazolinone; 6-chloro-3-methyl-2-[4-(3-piperidin-1-ylpropoxy)phenyl]pyrido[3,4-d]-pyrimidin-4(3H)-one; 2-[4-(1-cyclopentyl-4-piperidinyloxy)phenyl]-3-methylpyrido[2,3-d]-pyrimidin-4(3H)-one; treats metabolic, nervous system, vascular disorders
11/06/2008US20080275063 C-{4-[6-(2-Ethoxy-phenyl)-pyrimidin-4-ylamino]-phenyl}-N-propyl-methanesulfonamide; antiinflammatories, antiproliferatives, analgesics; cardiovascular disorders, neurodegenerative diseases; immunotherapy
11/06/2008US20080275060 N-Hydroxyamide Derivatives and Use Thereof
11/06/2008US20080275058 N-Substituted-1H-Quinoline-2,4-Diones, Preparation Method Thereof, And Pharmaceutical Composition Containing The Same
11/06/2008US20080275053 Heterocyclyl Compounds
11/06/2008US20080275046 1-(3-{4-[4-(piperidin-1-ylmethyl)-1,3-oxazol-2-yl]phenoxy}propyl)piperidine; 4,4-difluoro-1-[(4-methyl-2-{4-[3-(2-methylpyrrolidin-1-yl)propoxy]phenyl}-1,3-thiazol-5-yl)carbonyl]piperidine; histamine H3-receptor antagonists; Parkinson's and Alzheimer's diseases; sleep disorders; antiepileptics
11/06/2008US20080275044 Vanilloid receptor 1 antagonists; reducing a phenyl or 3-pyridyl carboxylic acid or ester to an alcohol, aziding, reduction to a primary amine, amidation with a (3-fluoro-4-methylsulfonamido)phenyl acetic acid; 2-(3-Fluoro-4-(methylsulfonamido)phenyl)-N-(substituted phenyl or pyrid-3-yl) acetamides
11/06/2008US20080275041 3-[5-({4-[2-(Dipropylamino)ethyl]piperazin-1-yl}sulfonyl)pyridin-2-yl]-2-hydroxy-1H-indole-6-carbonitrile hydrochloride; Alzheimer's Disease, Parkinson's Disease, depression, schizophrenia, HIV, Down syndrome, bone disorders, alopecia
11/06/2008US20080275040 8-(1-Piperazinyl)-Quinoline Derivatives and Their Use in the Treatment of Cns Disorders
11/06/2008US20080275038 Imidazopyridine Derivatives as A2b Adenosine Receptor Antagonists
11/06/2008US20080275037 2-Cyanophenyl fused heterocyclic compounds, and compositions and uses thereof
11/06/2008US20080275031 Inhibitors of C-FMS Kinase
11/06/2008US20080275028 Modulators or Alpha7 Nicotinic Acetylcholine Receptors and Therapeutic Uses Thereof
11/06/2008US20080275024 Amyloid precursor protein/gamma-secretase inhibitors; amides of aminobenzodiazepines: 2-(3,5-difluorophenyl)-N {[N-(1-methyl-2-oxo-5-phenyl((S)-3H-benzo[f]1,4-diazepin-3-yl))carbamoyl]cyclohexyl}acetamide
11/06/2008US20080275021 Pyrrolidine derivatives as dual nk1/nk3 receptor antagonists
11/06/2008US20080275010 Compositions and methods to prevent toxicity induced by nonsteroidal antiinflammatory drugs
11/06/2008US20080275006 Process for the Preparation and Isolation of Phosphatides
1 ... 638 639 640 641 642 643 644 645 646 647 648 649 650 651 652 653 654 655 656 657 658 ... 1833